☰

Sandhya Bangaru - Publications

Affiliations: 
2013-2017 Microbiology and Immunology Vanderbilt University School of Medicine, Nashville, TN, United States 
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Torrents de la Peña A, Sewall LM, de Paiva Froes Rocha R, Jackson AM, Pratap PP, Bangaru S, Cottrell CA, Mohanty S, Shaw AC, Ward AB. Increasing sensitivity of antibody-antigen interactions using photo-cross-linking. Cell Reports Methods. 3: 100509. PMID 37426749 DOI: 10.1016/j.crmeth.2023.100509  0.498
2023 Radić L, Sliepen K, Yin V, Brinkkemper M, Capella-Pujol J, Schriek AI, Torres JL, Bangaru S, Burger JA, Poniman M, Bontjer I, Bouhuijs JH, Gideonse D, Eggink D, Ward AB, et al. Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses. Iscience. 26: 106540. PMID 37063468 DOI: 10.1016/j.isci.2023.106540  0.46
2023 Hurtado J, Rogers TF, Jaffe DB, Adams BA, Bangaru S, Garcia E, Capozzola T, Messmer T, Sharma P, Song G, Beutler N, He W, Dueker K, Musharrafieh R, Stubbington MJT, et al. Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes. Biorxiv : the Preprint Server For Biology. PMID 37034676 DOI: 10.1101/2023.03.28.534602  0.764
2022 Tas JMJ, Koo JH, Lin YC, Xie Z, Steichen JM, Jackson AM, Hauser BM, Wang X, Cottrell CA, Torres JL, Warner JE, Kirsch KH, Weldon SR, Groschel B, Nogal B, ... ... Bangaru S, et al. Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses. Immunity. PMID 35987201 DOI: 10.1016/j.immuni.2022.07.020  0.469
2022 Bangaru S, Antanasijevic A, Kose N, Sewall LM, Jackson AM, Suryadevara N, Zhan X, Torres JL, Copps J, de la Peña AT, Crowe JE, Ward AB. Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Science Advances. 8: eabn2911. PMID 35507649 DOI: 10.1126/sciadv.abn2911  0.466
2021 Cho H, Gonzales-Wartz KK, Huang D, Yuan M, Peterson M, Liang J, Beutler N, Torres JL, Cong Y, Postnikova E, Bangaru S, Talana CA, Shi W, Yang ES, Zhang Y, et al. Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern. Science Translational Medicine. eabj5413. PMID 34519517 DOI: 10.1126/scitranslmed.abj5413  0.449
2021 Gilchuk IM, Bangaru S, Kose N, Bombardi RG, Trivette A, Li S, Turner HL, Carnahan RH, Ward AB, Crowe JE. Human antibody recognition of H7N9 influenza virus hemagglutinin following natural infection. Jci Insight. PMID 34437301 DOI: 10.1172/jci.insight.152403  0.84
2021 Amanat F, Strohmeier S, Lee WH, Bangaru S, Ward AB, Coughlan L, Krammer F. Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect in a Mouse Model in a Neutralization-Dependent Manner. Mbio. e0100221. PMID 34311574 DOI: 10.1128/mBio.01002-21  0.605
2021 Zost SJ, Dong J, Gilchuk IM, Gilchuk P, Thornburg NJ, Bangaru S, Kose N, Finn JA, Bombardi R, Soto C, Chen EC, Nargi RS, Sutton RE, Irving RP, Suryadevara N, et al. Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface. The Journal of Clinical Investigation. PMID 34156974 DOI: 10.1172/JCI146791  0.723
2021 Liu H, Yuan M, Huang D, Bangaru S, Zhao F, Lee CD, Peng L, Barman S, Zhu X, Nemazee D, Burton DR, van Gils MJ, Sanders RW, Kornau HC, Reincke SM, et al. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host & Microbe. PMID 33894127 DOI: 10.1016/j.chom.2021.04.005  0.625
2021 Cho H, Gonzales-Wartz KK, Huang D, Yuan M, Peterson M, Liang J, Beutler N, Torres JL, Cong Y, Postnikova E, Bangaru S, Talana CA, Shi W, Yang ES, Zhang Y, et al. Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 33821267 DOI: 10.1101/2021.04.01.437942  0.521
2021 Liu H, Yuan M, Huang D, Bangaru S, Lee CD, Peng L, Zhu X, Nemazee D, van Gils MJ, Sanders RW, Kornau HC, Reincke SM, Pruss H, Kreye J, Wu NC, et al. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Biorxiv : the Preprint Server For Biology. PMID 33594361 DOI: 10.1101/2021.02.11.430866  0.61
2020 Kirchdoerfer RN, Bhandari M, Martini O, Sewall LM, Bangaru S, Yoon KJ, Ward AB. Structure and immune recognition of the porcine epidemic diarrhea virus spike protein. Structure (London, England : 1993). PMID 33378641 DOI: 10.1016/j.str.2020.12.003  0.451
2020 Wu NC, Yuan M, Bangaru S, Huang D, Zhu X, Lee CD, Turner HL, Peng L, Yang L, Burton DR, Nemazee D, Ward AB, Wilson IA. A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. Plos Pathogens. 16: e1009089. PMID 33275640 DOI: 10.1371/journal.ppat.1009089  0.438
2020 Liu H, Wu NC, Yuan M, Bangaru S, Torres JL, Caniels TG, van Schooten J, Zhu X, Lee CD, Brouwer PJM, van Gils MJ, Sanders RW, Ward AB, Wilson IA. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity. PMID 33242394 DOI: 10.1016/j.immuni.2020.10.023  0.521
2020 Bangaru S, Ozorowski G, Turner HL, Antanasijevic A, Huang D, Wang X, Torres JL, Diedrich JK, Tian JH, Portnoff AD, Patel N, Massare MJ, Yates JR, Nemazee D, Paulson JC, et al. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. Science (New York, N.Y.). PMID 33082295 DOI: 10.1126/science.abe1502  0.389
2020 Wu NC, Yuan M, Liu H, Lee CD, Zhu X, Bangaru S, Torres JL, Caniels TG, Brouwer PJM, van Gils MJ, Sanders RW, Ward AB, Wilson IA. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Reports. 108274. PMID 33027617 DOI: 10.1016/j.celrep.2020.108274  0.461
2020 Wu NC, Yuan M, Bangaru S, Huang D, Zhu X, Lee CD, Turner HL, Peng L, Yang L, Nemazee D, Ward AB, Wilson IA. A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. Biorxiv : the Preprint Server For Biology. PMID 32995788 DOI: 10.1101/2020.09.21.305441  0.438
2020 Liu H, Wu NC, Yuan M, Bangaru S, Torres JL, Caniels TG, van Schooten J, Zhu X, Lee CD, Brouwer PJM, van Gils MJ, Sanders RW, Ward AB, Wilson IA. Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity. Biorxiv : the Preprint Server For Biology. PMID 32793906 DOI: 10.1101/2020.08.02.233536  0.527
2020 Bangaru S, Ozorowski G, Turner HL, Antanasijevic A, Huang D, Wang X, Torres JL, Diedrich JK, Tian JH, Portnoff AD, Patel N, Massare MJ, Yates JR, Nemazee D, Paulson JC, et al. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. Biorxiv : the Preprint Server For Biology. PMID 32793901 DOI: 10.1101/2020.08.06.234674  0.389
2020 Wu NC, Yuan M, Liu H, Lee CD, Zhu X, Bangaru S, Torres JL, Caniels TG, Brouwer PJM, van Gils MJ, Sanders RW, Ward AB, Wilson IA. An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain. Biorxiv : the Preprint Server For Biology. PMID 32743580 DOI: 10.1101/2020.07.26.222232  0.461
2020 Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, Aldon Y, Bangaru S, Torres JL, Okba NMA, Claireaux M, Kerster G, Bentlage AEH, van Haaren MM, Guerra D, Burger JA, Schermer EE, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science (New York, N.Y.). PMID 32540902 DOI: 10.1126/Science.Abc5902  0.598
2019 Gilchuk IM, Bangaru S, Gilchuk P, Irving RP, Kose N, Bombardi RG, Thornburg NJ, Creech CB, Edwards KM, Li S, Turner HL, Yu W, Zhu X, Wilson IA, Ward AB, et al. Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice. Cell Host & Microbe. PMID 31757769 DOI: 10.1016/J.Chom.2019.10.003  0.843
2019 Zhu X, Turner HL, Lang S, McBride R, Bangaru S, Gilchuk IM, Yu W, Paulson JC, Crowe JE, Ward AB, Wilson IA. Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies. Cell Host & Microbe. PMID 31757767 DOI: 10.1016/J.Chom.2019.10.002  0.86
2019 Bangaru S, Lang S, Schotsaert M, Vanderven HA, Zhu X, Kose N, Bombardi R, Finn JA, Kent SJ, Gilchuk P, Gilchuk I, Turner HL, García-Sastre A, Li S, Ward AB, et al. A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface. Cell. 177: 1136-1152.e18. PMID 31100268 DOI: 10.1016/J.Cell.2019.04.011  0.799
2019 Turner HL, Pallesen J, Lang S, Bangaru S, Urata S, Li S, Cottrell CA, Bowman CA, Crowe JE, Wilson IA, Ward AB. Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains. Plos Biology. 17: e3000139. PMID 30716060 DOI: 10.1371/Journal.Pbio.3000139  0.778
2018 Bangaru S, Zhang H, Gilchuk IM, Voss TG, Irving RP, Gilchuk P, Matta P, Zhu X, Lang S, Nieusma T, Richt JA, Albrecht RA, Vanderven HA, Bombardi R, Kent SJ, et al. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nature Communications. 9: 2669. PMID 29991715 DOI: 10.1038/S41467-018-04704-9  0.874
2016 Bangaru S, Nieusma T, Kose N, Thornburg NJ, Finn JA, Kaplan BS, King HG, Singh V, Lampley RM, Sapparapu G, Cisneros A, Edwards KM, Slaughter JC, Edupuganti S, Lai L, et al. Recognition of influenza H3N2 variant virus by human neutralizing antibodies. Jci Insight. 1. PMID 27482543 DOI: 10.1172/Jci.Insight.86673  0.725
2016 Thornburg NJ, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley RM, Bombardi RG, Yu Y, Graham S, Branchizio A, Yoder SM, Rock MT, Creech CB, Edwards KM, Lee D, et al. H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. The Journal of Clinical Investigation. PMID 26950424 DOI: 10.1172/Jci85317  0.834
2015 Keitel WA, Jackson LA, Edupuganti S, Winokur PL, Mulligan MJ, Thornburg NJ, Patel SM, Rouphael NG, Lai L, Bangaru S, McNeal MM, Bellamy AR, Hill HR. Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old. The Journal of Infectious Diseases. 212: 552-61. PMID 25649171 DOI: 10.1093/Infdis/Jiv056  0.759
2012 Gorman J, McLellan J, Yang Y, Zhou T, Zhu J, Bangaru S, Bayless N, Alff P, Marshall C, Kwong P. Recombinant Env proteins that bind the quaternary-specific, V1/V2-directed PGT antibodies Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-P84  0.313
Show low-probability matches.